Trademark: 97533908
Word
CAIDYA
Status Date
Tuesday, March 19, 2024
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, January 23, 2024
41 Consultation in the field of publishing and issuing scientific papers in relation to conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and clinical performance improvement in the field of international health and in the pharmaceutical, biotechnology, and medical device industries
9 Computer software, namely, downloadable computer programs and downloadable computer programs provided via a website for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials, computer program systems consisting of computer hardware and recorded software systems for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials and program libraries in the nature of electronic databases recorded on a data carrier in the field of pharmaceutical research and development and printed and electronic users manuals for use therewith sold as a unit
39 Clinical trial logistical services, namely, delivering clinical trial kits to sites, delivering wearable devices to patients and/or site locations
38 Providing user access to a global computer network in connection with clinical trials and drug development; Provision of access to a computer network in connection with clinical trials and drug development
37 Real estate site selection namely, building inspecting in the course of building construction of potential sites for hosting clinical trials
44 Medical and pharmaceutical consultation
10 Study equipment for clinical trials, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters, medical imaging devices for the brain, and similar medical apparatus for detecting symptoms related to specific disease types in the fields of cardiology, cell and genes, gastroenterology, infectious diseases, nephrology, neurology, oncology, rare diseases, respiratory, and women's health, for use in clinical trials
42 Inspecting potential sites for hosting clinical trials for quality control purposes; providing temporary use of web-based computer software programs for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials
The mark consists of the stylized wording "CAIDYA" with the stylized letters "C" and "A" intertwined together to form an infinity symbol and appearing in the color pink.
The color(s) pink is/are claimed as a feature of the mark.
The wording "CAIDYA" has no meaning in a foreign language.
Mar 19, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Published For Opposition
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Dec 16, 2023
Approved For Pub - Principal Register
Dec 16, 2023
Examiner's Amendment Entered
Dec 16, 2023
Notification Of Examiners Amendment E-Mailed
Dec 16, 2023
Examiners Amendment E-Mailed
Dec 16, 2023
Examiners Amendment -Written
Dec 2, 2023
Teas/Email Correspondence Entered
Dec 1, 2023
Correspondence Received In Law Office
Dec 1, 2023
Teas Response To Office Action Received
Sep 5, 2023
Application Extension Granted/Receipt Provided
Sep 5, 2023
Application Extension To Response Period - Received
Jun 2, 2023
Notification Of Non-Final Action E-Mailed
Jun 2, 2023
Non-Final Action E-Mailed
Jun 2, 2023
Non-Final Action Written
May 19, 2023
Assigned To Examiner
Aug 26, 2022
Notice Of Design Search Code E-Mailed
Aug 25, 2022
New Application Office Supplied Data Entered
Aug 6, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
